Cortical bone viscoelastic damping assessed with resonant ultrasound spectroscopy reflects porosity and mineral content.

Cortical bone Damping Mineral content Porosity Quality factor Resonant ultrasound spectroscopy

Journal

Journal of the mechanical behavior of biomedical materials
ISSN: 1878-0180
Titre abrégé: J Mech Behav Biomed Mater
Pays: Netherlands
ID NLM: 101322406

Informations de publication

Date de publication:
05 2021
Historique:
received: 07 08 2020
revised: 08 01 2021
accepted: 04 02 2021
pubmed: 27 2 2021
medline: 15 5 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

Viscoelasticity is an essential property of bone related to fragility, which is altered in aging and bone disease. Bone viscoelastic behavior is attributed to several mechanisms involving collagen and mineral properties, porosities, and bone hierarchical tissue organization. We aimed to assess the relationships between cortical bone viscoelastic damping measured with Resonant Ultrasound Spectroscopy (RUS), microstructural and compositional characteristics. We measured 52 bone specimens from the femur of 26 elderly human donors. RUS provided a shear damping coefficient at a frequency of the order of 150 kHz. The characteristics of the structure of the vascular pore network and tissue mineral density were measured using synchrotron radiation high-resolution computed tomography (SR-μCT). Fourier transformed infrared microspectroscopy (FTIRM) was used to quantify mineral-to-organic phase ratio, mineral maturity, crystallinity, and collagen maturity. Cross-links were quantified from biochemistry. Viscoelastic damping was found to increase with vascular porosity (r=0.68), to decrease with the degree of mineralization of the extravascular matrix (r=-0.68), and was marginally affected by collagen. We built a multilinear model suggesting that when porosity is controlled, the variation of mineral content explains a small additional part of the variability of damping. The work supports the consideration of viscoelasticity measurement as a potential biomarker of fragility and provides a documentation of bone viscoelastic behavior and its determinants in a frequency range rarely investigated.

Identifiants

pubmed: 33636678
pii: S1751-6161(21)00077-1
doi: 10.1016/j.jmbbm.2021.104388
pii:
doi:

Substances chimiques

Minerals 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104388

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Fan Fan (F)

Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, 100083, Beijing, China; Sorbonne Université, INSERM UMR-S 1146, CNRS UMR 7371, Laboratoire d'Imagerie Biomédicale, F-75006, Paris, France. Electronic address: fanfan@buaa.edu.cn.

Xiran Cai (X)

Sorbonne Université, INSERM UMR-S 1146, CNRS UMR 7371, Laboratoire d'Imagerie Biomédicale, F-75006, Paris, France; School of Information Science and Technology, ShanghaiTech University, 201210, Shanghai, China.

Hélène Follet (H)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM, LYOS UMR 1033, F-69008, Lyon, France.

Françoise Peyrin (F)

Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, F-69621, Lyon, France.

Pascal Laugier (P)

Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, 100083, Beijing, China; Sorbonne Université, INSERM UMR-S 1146, CNRS UMR 7371, Laboratoire d'Imagerie Biomédicale, F-75006, Paris, France.

Haijun Niu (H)

Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, 100083, Beijing, China.

Quentin Grimal (Q)

Sorbonne Université, INSERM UMR-S 1146, CNRS UMR 7371, Laboratoire d'Imagerie Biomédicale, F-75006, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH